Though blockchain remains very much a work in progress for health insurers, one of the industry’s first significant forays into the technology is yielding promising early returns.
Though blockchain remains very much a work in progress for health insurers, one of the industry’s first significant forays into the technology is yielding promising early returns.
The Synaptic Health Alliance was formed in 2018 by Aetna, UnitedHealth Group and Humana; a provider network, MultiPlan Corp.; and Quest Diagnostics, the testing company. It is still going strong after three years, according to Mark Taylor, a spokesman for Humana.
“Synaptic Health Alliance's pilot program has transitioned to a live product that is creating value for the alliance members,” he told Managed Healthcare Executive®. “It is incorporated into operational processes and expanding to include additional geographic areas.”
The program is focused on using blockchain to improve provider directories. Blockchain makes it possible to more quickly share up-to-date provider demographic data, ultimately cutting administrative costs while also increasing the quality and accuracy of the data in the directories.
“A decentralized approach to exchanging information allows companies to avoid building duplicative point-to-point connections,” he explained.
Taylor said one of the challenges to implementing blockchain technology is that it requires companies to rethink how they interact with each other. “Many of the challenges are not technical, but more related to different approaches to governance, ownership and a new decentralized architecture,” he said.
Another sticking pointing is projecting the financial benefits of blockchain-enabled efficiencies, Taylor said. But progress being made by the alliance and others is building confidence, he said.
The Synaptic Health Alliance members have found ways to build incentives into their program in order to ensure the program is financially stable and mutually beneficial for all the members, noted Taylor.
The alliance recently added five new members, including the 52-hospital Providence health system. As more members join, Taylor hopes the experiment can eventually spark broader implementation of blockchain within the healthcare industry. “It will take a significant effort to make a change of this magnitude, given the complexities of the healthcare ecosystem,” he said. “But the possibility is there.”
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Phase 3 Trial of Vertex’s Islet Cell Therapy for Type 1 Diabetes Under Way
April 23rd 2025Zimislecel is an allogeneic stem cell-derived islet cell therapy that could eliminate the need for insulin in those who have type 1 diabetes. Regulatory submissions are expected in 2026, and if approved, would be the second cell therapy for type 1 diabetes.
Read More